$ADPT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adaptive Biotechnologies Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Adaptive Biotechnologies Corp. Get notifications about new insider transactions in Adaptive Biotechnologies Corp for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 11 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 21 2021 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Sell | M | 4.07 | 23,000 | 93,610 | 35,000 | 58 K to 35 K (-39.66 %) |
Jan 21 2021 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Buy | M | 0.84 | 2,000 | 1,680 | 12,000 | 10 K to 12 K (+20.00 %) |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.27 | 417 | 2,615 | 1,250 | |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 69.00 | 417 | 28,773 | 0 | 417 to 0 (-100.00 %) |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.27 | 417 | 2,615 | 417 | 0 to 417 |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 230,000 | |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 67.19 | 1,491 | 100,180 | 0 | 1.5 K to 0 (-100.00 %) |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 66.47 | 8,802 | 585,069 | 1,491 | 10.3 K to 1.5 K (-85.51 %) |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 65.47 | 4,707 | 308,167 | 10,293 | 15 K to 10.3 K (-31.38 %) |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 57,000 | |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 67.05 | 622 | 41,705 | 0 | 622 to 0 (-100.00 %) |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 66.34 | 1,378 | 91,417 | 622 | 2 K to 622 (-68.90 %) |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Option Exercise | M | 7.80 | 2,000 | 15,600 | 159,000 | |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Sell | S | 66.89 | 1,110 | 74,248 | 0 | 1.1 K to 0 (-100.00 %) |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Sell | S | 66.12 | 890 | 58,847 | 1,110 | 2 K to 1.1 K (-44.50 %) |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Buy | M | 7.80 | 2,000 | 15,600 | 2,000 | 0 to 2 K |
Jan 15 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 245,000 | |
Jan 15 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 260,000 | |
Jan 15 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 66.35 | 2,461 | 163,287 | 0 | 2.5 K to 0 (-100.00 %) |
Jan 15 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 65.48 | 12,539 | 821,054 | 2,461 | 15 K to 2.5 K (-83.59 %) |
Jan 15 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
Jan 15 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 63.72 | 6,885 | 438,712 | 0 | 6.9 K to 0 (-100.00 %) |
Jan 15 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 62.79 | 8,115 | 509,541 | 6,885 | 15 K to 6.9 K (-54.10 %) |
Jan 15 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
Jan 15 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | M | 7.80 | 6,000 | 46,800 | 95,000 | |
Jan 15 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 66.43 | 959 | 63,706 | 0 | 959 to 0 (-100.00 %) |
Jan 15 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 65.77 | 5,041 | 331,547 | 959 | 6 K to 959 (-84.02 %) |
Jan 15 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Buy | M | 7.80 | 6,000 | 46,800 | 6,000 | 0 to 6 K |
Jan 15 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 50,000 | 316,000 | 365,000 | |
Jan 15 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 63.63 | 34,180 | 2,174,873 | 1,000 | 35.2 K to 1,000 (-97.16 %) |
Jan 15 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 62.92 | 15,820 | 995,394 | 35,180 | 51 K to 35.2 K (-31.02 %) |
Jan 15 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 50,000 | 316,000 | 51,000 | 1,000 to 51 K (+5,000.00 %) |
Jan 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 75,000 | 474,000 | 415,000 | |
Jan 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 63.73 | 1,200 | 76,476 | 1,000 | 2.2 K to 1,000 (-54.55 %) |
Jan 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 62.96 | 33,827 | 2,129,748 | 2,200 | 36 K to 2.2 K (-93.89 %) |
Jan 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 62.25 | 39,973 | 2,488,319 | 36,027 | 76 K to 36 K (-52.60 %) |
Jan 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 75,000 | 474,000 | 76,000 | 1,000 to 76 K (+7,500.00 %) |
Jan 13 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 275,000 | |
Jan 13 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 290,000 | |
Jan 13 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 63.10 | 5,128 | 323,577 | 0 | 5.1 K to 0 (-100.00 %) |
Jan 13 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 62.47 | 9,872 | 616,704 | 5,128 | 15 K to 5.1 K (-65.81 %) |
Jan 13 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
Jan 13 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 61.74 | 9,756 | 602,335 | 0 | 9.8 K to 0 (-100.00 %) |
Jan 13 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 60.68 | 2,544 | 154,370 | 9,756 | 12.3 K to 9.8 K (-20.68 %) |
Jan 13 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.62 | 2,700 | 160,974 | 12,300 | 15 K to 12.3 K (-18.00 %) |
Jan 13 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
Jan 11 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 305,000 | |
Jan 11 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 61.35 | 4,944 | 303,314 | 0 | 4.9 K to 0 (-100.00 %) |
Jan 11 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | S | 60.44 | 6,186 | 373,882 | 4,944 | -1,242 to 4.9 K (-498.07 %) |
Jan 11 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.70 | 2,213 | 132,116 | 11,130 | 13.3 K to 11.1 K (-16.59 %) |
Jan 11 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 58.82 | 1,657 | 97,465 | 13,343 | 15 K to 13.3 K (-11.05 %) |
Jan 11 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 350,000 | |
Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 365,000 | |
Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 56.56 | 363 | 20,531 | 0 | 363 to 0 (-100.00 %) |
Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 55.98 | 14,637 | 819,379 | 363 | 15 K to 363 (-97.58 %) |
Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.40 | 709 | 42,115 | 0 | 709 to 0 (-100.00 %) |
Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 58.09 | 4,751 | 275,986 | 709 | 5.5 K to 709 (-87.01 %) |
Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 57.52 | 3,169 | 182,281 | 5,460 | 8.6 K to 5.5 K (-36.72 %) |
Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 56.05 | 6,371 | 357,095 | 8,629 | 15 K to 8.6 K (-42.47 %) |
Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 320,000 | |
Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 335,000 | |
Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 57.30 | 15,000 | 859,500 | 0 | 15 K to 0 (-100.00 %) |
Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 55.45 | 808 | 44,804 | 0 | 808 to 0 (-100.00 %) |
Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 54.86 | 14,192 | 778,573 | 808 | 15 K to 808 (-94.61 %) |
Jan 07 2021 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Option Exercise | M | 6.32 | 10,000 | 63,200 | 35,000 | |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Sell | S | 59.46 | 400 | 23,784 | 0 | 400 to 0 (-100.00 %) |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Sell | S | 58.67 | 592 | 34,733 | 400 | 992 to 400 (-59.68 %) |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Sell | S | 57.76 | 5,725 | 330,676 | 992 | 6.7 K to 992 (-85.23 %) |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Sell | S | 56.10 | 3,283 | 184,176 | 6,717 | 10 K to 6.7 K (-32.83 %) |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Buy | M | 6.32 | 10,000 | 63,200 | 10,000 | 0 to 10 K |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 7.27 | 1,563 | 11,363 | 37,500 | |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 54,688 | |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 26,042 | |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 59.46 | 267 | 15,876 | 0 | 267 to 0 (-100.00 %) |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 58.63 | 495 | 29,022 | 267 | 762 to 267 (-64.96 %) |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 57.82 | 3,800 | 219,716 | 762 | 4.6 K to 762 (-83.30 %) |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 56.12 | 2,209 | 123,969 | 4,562 | 6.8 K to 4.6 K (-32.62 %) |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 7.27 | 1,563 | 11,363 | 6,771 | 5.2 K to 6.8 K (+30.01 %) |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 5,208 | 2.6 K to 5.2 K (+100.00 %) |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 2,604 | 0 to 2.6 K |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 6.55 | 1,771 | 11,600 | 26,563 | |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 6.55 | 1,771 | 11,600 | 26,563 | |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 7.80 | 4,759 | 37,120 | 29,167 | |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 7.80 | 4,759 | 37,120 | 29,167 | |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 59.27 | 391 | 23,175 | 1,300 | 1.7 K to 1.3 K (-23.12 %) |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 59.27 | 391 | 23,175 | 1,300 | 1.7 K to 1.3 K (-23.12 %) |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 58.40 | 1,610 | 94,024 | 1,691 | 3.3 K to 1.7 K (-48.77 %) |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 58.40 | 1,610 | 94,024 | 1,691 | 3.3 K to 1.7 K (-48.77 %) |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 57.54 | 4,529 | 260,599 | 3,301 | 7.8 K to 3.3 K (-57.84 %) |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 57.54 | 4,529 | 260,599 | 3,301 | 7.8 K to 3.3 K (-57.84 %) |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 6.55 | 1,771 | 11,600 | 7,830 | 6.1 K to 7.8 K (+29.23 %) |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 6.55 | 1,771 | 11,600 | 7,830 | 6.1 K to 7.8 K (+29.23 %) |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 7.80 | 4,759 | 37,120 | 6,059 | 1.3 K to 6.1 K (+366.08 %) |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 7.80 | 4,759 | 37,120 | 6,059 | 1.3 K to 6.1 K (+366.08 %) |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 380,000 | |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 380,000 | |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.27 | 638 | 37,814 | 0 | 638 to 0 (-100.00 %) |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.27 | 638 | 37,814 | 0 | 638 to 0 (-100.00 %) |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 58.25 | 6,386 | 371,985 | 638 | 7 K to 638 (-90.92 %) |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 58.25 | 6,386 | 371,985 | 638 | 7 K to 638 (-90.92 %) |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 57.56 | 7,976 | 459,099 | 7,024 | 15 K to 7 K (-53.17 %) |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 57.56 | 7,976 | 459,099 | 7,024 | 15 K to 7 K (-53.17 %) |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
Dec 31 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,520 | 5,452 | 0 | |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,790 | 5,541 | 16,520 | |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,250 | 5,363 | 33,310 | |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.65 | 8,869 | 529,036 | 1,778,180 | 1.8 M to 1.8 M (-0.50 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,520 | 5,452 | 0 | |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.20 | 7,651 | 452,939 | 1,787,049 | 1.8 M to 1.8 M (-0.43 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,790 | 5,541 | 16,520 | |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,520 | 5,452 | 1,794,700 | 1.8 M to 1.8 M (+0.93 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,250 | 5,363 | 33,310 | |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 60.73 | 1,700 | 103,241 | 1,778,180 | 1.8 M to 1.8 M (-0.10 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.65 | 8,869 | 529,036 | 1,778,180 | 1.8 M to 1.8 M (-0.50 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.42 | 6,834 | 406,076 | 1,779,880 | 1.8 M to 1.8 M (-0.38 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.20 | 7,651 | 452,939 | 1,787,049 | 1.8 M to 1.8 M (-0.43 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 58.87 | 8,256 | 486,031 | 1,786,714 | 1.8 M to 1.8 M (-0.46 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,520 | 5,452 | 1,794,700 | 1.8 M to 1.8 M (+0.93 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,790 | 5,541 | 1,794,970 | 1.8 M to 1.8 M (+0.94 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 60.73 | 1,700 | 103,241 | 1,778,180 | 1.8 M to 1.8 M (-0.10 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 63.41 | 100 | 6,341 | 1,778,180 | 1.8 M to 1.8 M (-0.01 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.42 | 6,834 | 406,076 | 1,779,880 | 1.8 M to 1.8 M (-0.38 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 62.60 | 1,500 | 93,900 | 1,778,280 | 1.8 M to 1.8 M (-0.08 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 58.87 | 8,256 | 486,031 | 1,786,714 | 1.8 M to 1.8 M (-0.46 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 61.48 | 1,108 | 68,120 | 1,779,780 | 1.8 M to 1.8 M (-0.06 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,790 | 5,541 | 1,794,970 | 1.8 M to 1.8 M (+0.94 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 60.71 | 13,542 | 822,135 | 1,780,888 | 1.8 M to 1.8 M (-0.75 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 63.41 | 100 | 6,341 | 1,778,180 | 1.8 M to 1.8 M (-0.01 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,250 | 5,363 | 1,794,430 | 1.8 M to 1.8 M (+0.91 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 62.60 | 1,500 | 93,900 | 1,778,280 | 1.8 M to 1.8 M (-0.08 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 395,000 | |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 61.48 | 1,108 | 68,120 | 1,779,780 | 1.8 M to 1.8 M (-0.06 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 410,000 | |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 60.71 | 13,542 | 822,135 | 1,780,888 | 1.8 M to 1.8 M (-0.75 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 425,000 | |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,250 | 5,363 | 1,794,430 | 1.8 M to 1.8 M (+0.91 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 60.12 | 1,700 | 102,204 | 0 | 1.7 K to 0 (-100.00 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 395,000 | |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.55 | 13,300 | 792,015 | 1,700 | 15 K to 1.7 K (-88.67 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 410,000 | |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 425,000 |